Herzog, T. J., Moore, K., Konstantinopoulos, P. A., Gilbert, L., Hays, J. L., Monk, B. J., O'Malley, D. M., Barlin, J. N., Graham, J. R., Desai, M., Wang, Y., Du, Y., Dalal, R., Coleman, R. L., & Sehouli, J. (n.d.). 2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68). International journal of gynecological cancer, 32, A255–A256. http://access.bl.uk/ark:/81055/vdc_100168340004.0x00003b